Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

XDG3

Xtrackers MSCI Global SDG 3 Good Health UCITS ETF

The XDG3 Exchange Traded Fund (ETF) is provided by Xtrackers by DWS. It is built to track an index: MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index. The XDG3 ETF provides physical exposure, so by buying it you actually own parts of all the 115 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

$40.44
N/A
Data as of 08/28/26
1D price range
N/A
52W price range
$33.57$41.36
YTD Perf.
+7.82%
YTD Flows
Annualized volatility
Fund AuM
€25M
Share class AuM
€25M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE00036F4K40
TER
0.35%
Inception date
1/18/2023
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Aug 28, 2026
-10%-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
98.01%
Consumer Non-Cyclicals
1.86%
Other
0.13%
Latest XDG3 news

No content available for this fund

FAQ about XDG3

XDG3 is a Passive ETF. This ETF provides exposure to Other Global Equities.
XDG3 tracks the MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index - USD, through a full replication replication method.
XDG3 carries a total expense ratio (TER) of 0.35%, indicating the annual cost for holding the fund.
XDG3 was introduced to the market on January 18, 2023. It trades on Sweden, among other exchanges
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF, XDG3, is provided by Xtrackers by DWS. Learn more about Xtrackers by DWS here.
XDG3 oversees €25M in assets as of August 28, 2026.
XDG3 follows a capitalizing, meaning it reinvests income within the fund.
As of July 31, 2026, XDG3 has significant geographic allocations in USA, United Kingdom and Denmark.
As of July 31, 2026, XDG3 focuses largely on Healthcare and Consumer Non-Cyclicals.
As of July 31, 2026, XDG3 holds 115 positions in its portfolio, with 62.94% of assets concentrated in its top 15 holdings.
As of July 31, 2026, XDG3 top three holdings include Thermo Fisher Scientific, Inc., AbbVie, Inc. and Eli Lilly & Co..
The base currency of XDG3 is USD.
Data as of 07/31/26
Thermo Fisher Scientific, Inc.
5.16%
AbbVie, Inc.
4.93%
Eli Lilly & Co.
4.79%
Danaher Corp.
4.78%
Johnson & Johnson
4.65%
Amgen, Inc.
4.65%
Merck & Co., Inc.
4.62%
Stryker Corp.
4.37%
Gilead Sciences, Inc.
4.12%
Novo Nordisk A/S
3.93%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight